Preventing synaptic deficits in Alzheimer’s disease by inhibiting tumor necrosis factor alpha signaling

The characterization of preclinical stages of Alzheimer’s disease (AD) would provide a therapeutic window for prevention. One of the challenges of developing preventive therapy for AD is to identify early biomarkers for intervention studies. We have recently shown that in the TgCRND8 transgenic AD m...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavanagh, Chelsea, Wong, Tak Pan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084902/
https://www.ncbi.nlm.nih.gov/pubmed/30135948
http://dx.doi.org/10.1016/j.ibror.2018.01.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084902/
https://www.ncbi.nlm.nih.gov/pubmed/30135948
http://dx.doi.org/10.1016/j.ibror.2018.01.003

Ejemplares similares